FILTER BY:
Evolving advances for the treatment of neovascular retinal diseases have t…
Expiration Date: 10/29/2021
Max Credits: 0.75
View Activity
Visual outcomes in patients with neovascular age-related macular degenerat…
Expiration Date: 10/20/2021
Max Credits: 1.25
Age-related macular degeneration (AMD), a leading cause of blindness in th…
Expiration Date: 4/12/2021
Outcomes for patients with neovascular retinal disease have been revolutio…
Expiration Date: 2/5/2021
Max Credits: 1
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy h…
Expiration Date: 12/15/2020
Max Credits: 0
The integration of intravitreal anti-vascular endothelial growth factor (a…
Expiration Date: 9/11/2020
The treatment of neovascular age-related macular degeneration (nAMD) has b…
Expiration Date: 8/27/2020
In the anti-vascular endothelial growth factor (VEGF) era, steroids, laser…
Expiration Date: 5/19/2020
Expiration Date: 5/2/2020
Diabetic retinopathy (DR) continues to be a leading cause of blindness. Ho…
Expiration Date: 4/8/2020